(Q30391605)

21 June 2017

title

Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience (English)

1 reference

21 June 2017

0 references

0 references

1 reference

Beate Sander

1

0 references

Allison McGeer

object named as

Allison McGeer

7

0 references

Murray Krahn

object named as

Murray Krahn

11

0 references

Chris T Bauch

2

object named as

Chris T Bauch

1 reference

21 June 2017

8

Janet Raboud

1 reference

21 June 2017

3

David Fisman

1 reference

21 June 2017

Robert A Fowler

4

1 reference

21 June 2017

Jeffrey C Kwong

5

1 reference

21 June 2017

Andreas Maetzel

6

1 reference

21 June 2017

Damon C Scales

9

1 reference

21 June 2017

Marija Zivkovic Gojovic

10

1 reference

21 June 2017

language of work or name

English

0 references

publication date

17 July 2010

1 reference

21 June 2017

1 reference

21 June 2017

volume

28

1 reference

21 June 2017

issue

38

1 reference

21 June 2017

page(s)

6210-6220

1 reference

Flu shots in Canada: are they getting to those who need them most?

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

The effect of universal influenza immunization on mortality and health care use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Modelling mitigation strategies for pandemic (H1N1) 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Containing pandemic influenza with antiviral agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Impact of influenza treatment with oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Effect of Influenza Treatment with Oseltamivir on Health Outcome and Costs in Otherwise Healthy Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Appropriate measures of influenza immunization program effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Utility scores for chronic conditions in a community-dwelling population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Finding optimal vaccination strategies for pandemic influenza using genetic algorithms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

Optimal pandemic influenza vaccine allocation strategies for the Canadian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.010

10.1016/J.VACCINE.2010.07.010

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference